USFDA conducts inspection at Zydus Lifesciences’ manufacturing facility in Ahmedabad

27 Mar 2023 Evaluate

The United States Food and Drug Administration (USFDA) has conducted an inspection at the manufacturing facility SEZ-1 of Zydus Lifesciences located at Pharmez, Ahmedabad from March 20 to 24, 2023. The inspection was a Pre-Approval Inspection (PAI) as well as a GMP Audit and concluded with three observations. There were no Data Integrity related observations. The company is addressing these observations and will respond to them within the stipulated time.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×